TFA Therapeutics, Inc. (RAJAF)
OTC: RAJAF · CIK 0001885680 · United States
Every official TFA Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RAJAF filings
TFA Therapeutics, Inc. documents
- TFA Therapeutics, Inc. 10-K 2026RAJAF 10-K 2026: annual report for fiscal 2026
- TFA Therapeutics, Inc. 10-K 2025RAJAF 10-K 2025: annual report for fiscal 2025
- TFA Therapeutics, Inc. 10-K 2024RAJAF 10-K 2024: annual report for fiscal 2024
- TFA Therapeutics, Inc. 10-K 2023RAJAF 10-K 2023: annual report for fiscal 2023
- TFA Therapeutics, Inc. 10-K 2022RAJAF 10-K 2022: annual report for fiscal 2022
- TFA Therapeutics, Inc. 10-Q 2026RAJAF 10-Q 2026: quarterly report for fiscal 2026
- TFA Therapeutics, Inc. 10-Q 2025RAJAF 10-Q 2025: quarterly report for fiscal 2025
- TFA Therapeutics, Inc. 10-Q 2024RAJAF 10-Q 2024: quarterly report for fiscal 2024
- TFA Therapeutics, Inc. 10-Q 2023RAJAF 10-Q 2023: quarterly report for fiscal 2023
- TFA Therapeutics, Inc. 10-Q 2022RAJAF 10-Q 2022: quarterly report for fiscal 2022
- TFA Therapeutics, Inc. 8-K 2026RAJAF 8-K 2026: current report for fiscal 2026
- TFA Therapeutics, Inc. 8-K 2025RAJAF 8-K 2025: current report for fiscal 2025
- TFA Therapeutics, Inc. 8-K 2024RAJAF 8-K 2024: current report for fiscal 2024
- TFA Therapeutics, Inc. 8-K 2023RAJAF 8-K 2023: current report for fiscal 2023
- TFA Therapeutics, Inc. 8-K 2022RAJAF 8-K 2022: current report for fiscal 2022
- TFA Therapeutics, Inc. DEF 14A 2026RAJAF DEF 14A 2026: proxy statement for fiscal 2026
- TFA Therapeutics, Inc. DEF 14A 2025RAJAF DEF 14A 2025: proxy statement for fiscal 2025
- TFA Therapeutics, Inc. DEF 14A 2024RAJAF DEF 14A 2024: proxy statement for fiscal 2024
- TFA Therapeutics, Inc. DEF 14A 2023RAJAF DEF 14A 2023: proxy statement for fiscal 2023
- TFA Therapeutics, Inc. DEF 14A 2022RAJAF DEF 14A 2022: proxy statement for fiscal 2022
- TFA Therapeutics, Inc. Form 4 2026RAJAF Form 4 2026: insider trading filing for fiscal 2026
- TFA Therapeutics, Inc. Form 4 2025RAJAF Form 4 2025: insider trading filing for fiscal 2025
- TFA Therapeutics, Inc. Form 4 2024RAJAF Form 4 2024: insider trading filing for fiscal 2024
- TFA Therapeutics, Inc. Form 4 2023RAJAF Form 4 2023: insider trading filing for fiscal 2023
- TFA Therapeutics, Inc. Form 4 2022RAJAF Form 4 2022: insider trading filing for fiscal 2022
- TFA Therapeutics, Inc. S-1 2026RAJAF S-1 2026: registration statement for fiscal 2026
- TFA Therapeutics, Inc. S-1 2025RAJAF S-1 2025: registration statement for fiscal 2025
- TFA Therapeutics, Inc. S-1 2024RAJAF S-1 2024: registration statement for fiscal 2024
- TFA Therapeutics, Inc. S-1 2023RAJAF S-1 2023: registration statement for fiscal 2023
- TFA Therapeutics, Inc. S-1 2022RAJAF S-1 2022: registration statement for fiscal 2022
- TFA Therapeutics, Inc. 13F 2026RAJAF 13F 2026: institutional holdings for fiscal 2026
- TFA Therapeutics, Inc. 13F 2025RAJAF 13F 2025: institutional holdings for fiscal 2025
- TFA Therapeutics, Inc. 13F 2024RAJAF 13F 2024: institutional holdings for fiscal 2024
- TFA Therapeutics, Inc. 13F 2023RAJAF 13F 2023: institutional holdings for fiscal 2023
- TFA Therapeutics, Inc. 13F 2022RAJAF 13F 2022: institutional holdings for fiscal 2022
More companies